Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ruth, Gilmore"'
Autor:
Mairead O’Donovan, Eimear Quinn, Kate Johnston, Evelyn Singleton, Julie Benson, Brian O'Mahony, Declan Noone, Cleona Duggan, Ruth Gilmore, Kevin Ryan, James S. O'Donnell, Niamh M. O’Connell
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 7, Pp n/a-n/a (2021)
Abstract Introduction In 2017, all people with severe hemophilia B in Ireland switched to recombinant factor IX Fc fusion protein concentrate (rFIXFc) prophylaxis. Patient‐reported outcomes (PROs) and health‐related quality of life (HRQoL) are im
Externí odkaz:
https://doaj.org/article/cce7db211eaf4a6f804488289b87edbe
Publikováno v:
Neurology. 100:879-883
Cerebral venous sinus thrombosis (CVST) is uncommon. Risk factors include inherited and acquired factors. Rapid diagnosis and treatment is essential and can help prevent complications, which can include seizures and visual disturbance. A 25-year-old
Autor:
Niamh M O'Connell, Catherine Bergin, Mary Byrne, Julie Benson, Kevin M. Ryan, Rachel Bird, Evelyn Singleton, Sheila Roche, Eimear Quinn, Cleona Duggan, Ruth Gilmore, Mairead O'Donovan, James S. O’Donnell
Publikováno v:
Haemophilia. 27:618-625
Introduction In 2017, all people with severe haemophilia B (PWSHB) in Ireland switched from standard half-life (SHL) recombinant FIX (rFIX) to rFIX Fc fusion protein (rFIXFc) prophylaxis. Aims To evaluate prophylaxis regimens, bleeding rates and fact
Autor:
Kevin M. Ryan, James S. O’Donnell, Catherine Bergin, Cleona Duggan, Niamh M O'Connell, Evelyn Singleton, Mairead O'Donovan, Ruth Gilmore, Mark McGowan, Alison Dougall, Rachel Bird, Sheila Roche, Mary Byrne, Julie Benson
Publikováno v:
Haemophilia. 27
Introduction Recombinant factor IX fusion protein concentrate (rFIXFc) is increasingly used for prophylaxis in people with haemophilia B (PWHB), but experience in the perioperative setting is limited. Aims To evaluate real-world perioperative factor
Autor:
Ingulsrud, Ruth Gilmore
Publikováno v:
Cricket; Oct2024, Vol. 52 Issue 2, p44-44, 1p, 1 Cartoon or Caricature
Autor:
Tom O’Gorman, Dara Byrne, Áine de Bhulbh, Ruth Gilmore, Margeret Coohill, Bronwyn Reid-McDermott
Publikováno v:
Poster Presentations.
Background The primary cause of preventable trauma-related death is major haemorrhage. Activation of a Massive Transfusion Protocol (MTP) or ‘Code Red’ initiates the rapid and continuous supply of a large volume of blood products during life-thre
Publikováno v:
Transfusion. 56:873-877
BACKGROUND Most recently described human platelet antigens (HPAs) have been low-frequency polymorphisms identified in cases of fetomaternal alloimmune thrombocytopenia (FMAIT). There is limited opportunity to study the clinical significance or differ
Autor:
Ann Green, Kay Ridgwell, Piers Walser, Marcin J. Woźniak, Geoff Lucas, Anthony Poles, Joan Fitzgerald, Ruth Gilmore
Publikováno v:
Transfusion. 53:1965-1973
Background Most recently described human platelet antigens (HPAs) have been detected in cases of fetomaternal alloimmune thrombocytopenia (FMAIT) where the mother has been immunized against a low-frequency antigen that the fetus has inherited from th
This environmental history of the Red River Valley from the mid 1850s – 2000 encompasses those who lived in this tallgrass prairie region and asks how did they live within this environment? In addition, it seeks to understand how they utilized thei
Externí odkaz:
http://hdl.handle.net/10365/25560
Autor:
James S. O’Donnell, Christopher L. Bacon, Barry White, Ruth Gilmore, C Ryan, P. Vince Jenkins, Beatrice Nolan, Catherine Keohane, Evelyn Singleton, Bridin Brady
Publikováno v:
Haemophilia. 17:407-411
Summary. Previous studies have suggested that development of inhibitors in previously treated patients (PTPs) may be attributable to a switch in factor VIII (FVIII) therapeutic product. Consequently, it is widely recognized that inhibitor development